Cash Secured Put vs Covered Call: What’s the Difference and Which Strategy Should You Use?
From the basic differences between a call vs put to more nuanced strategies like long calls vs covered calls, there are so many different ways to navigate the options trading realm. But today, we’re going to put two very similar, yet different, strategies side by side: cash secured put vs covered call. A cash-secured put involves selling a put option [...]
Lovesac Stock Jumps 25% on Q2 Earnings Results, But Is This Reason Enough to BUY LOVE?
Lovesac Co. (LOVE) has gained more than 24% so far Thursday morning after delivering a somewhat mixed bag for the second quarter of fiscal 2025. The company saw sales climb, yet profits shrunk. Still, the company managed to beat the analyst expectations on both the top and bottom lines for Q2. The loss of $0.38 per share was much [...]
The Presidential Debate is Affecting Trump’s Media Company: 3 Things DJT Investors Need to See
The debate America has long been anticipating took place last night between former president Donald Trump and current Vice President Kamala Harris. The general consensus as of Wednesday morning is that Trump put on a somewhat rocky performance, with many believing Harris performed better than expected. Even conservative voters aren’t thrilled with what they saw from their candidate. Shares [...]
What the EU’s Court Verdict Means for Apple: Plus, 3 Other Things for AAPL Investors to Consider
It was a bad day for tech companies in the European Union (EU) court system as both Apple (AAPL) and Google (GOOGL) lost their battles and will face hefty financial penalties as a result. Apple was fighting a €13 billion ($14.4 billion) Irish tax bill, which can be traced all the way back to 2016. CEO Tim Cook says [...]
Average Return Selling Covered Calls
Of all the different ways to make money with options, selling covered calls has become increasingly popular for its consistency and ease of implementation. It’s a great way to earn supplemental income on a stock you own that isn’t moving much. But, let’s get more specific. What is the average return selling covered calls? A quick scan of the web [...]
Vaxcyte Trial Results Suggest it Could Compete With Pfizer: Is it Worth Buying This Stock Today?
Earlier this week Vaxcyte (PCVX) shared an update on its VAX-31 trial results, which are quite promising. The stock popped nearly 50% on the news, sending shares to an all-time high of $115/share. VAX-31 is the company’s pneumococcal conjugate vaccine. This disease can contribute to more serious illnesses such as pneumonia, meningitis, and various ear and sinus infections. The [...]
